InvestorsHub Logo
Followers 22
Posts 1379
Boards Moderated 0
Alias Born 03/31/2017

Re: BonelessCat post# 341535

Tuesday, 01/26/2021 8:17:14 AM

Tuesday, January 26, 2021 8:17:14 AM

Post# of 403741
Great post LilKahuna. And, there is not as much money in curing people with a therapeutic vs. inoculating billions with a vaccine each year.

Go Leo & IPIX!

Quote:
15yrs and nothing seen-through to approval. Nothing seen through a P3 even.

Not unusual. Yes, including the time for Polymedix prior to IPIX, B has been in development for 15 years. When there is no urgent need, or there’s been no government focus, vaccines and therapeutics can take decades.

The current spate of mRNA vaccines have been in development for more than 30 years. If it weren’t for a pandemic Big Pharma was probably at least 5 years or more away from consideration of approval. More importantly, last March the Covid task force prioritized vaccines over therapeutics. Lots of money for vaccines, almost none for therapeutics.

Now that there are vaccines, the focus will turn to therapies for those the vaccines have yet to reach. At 1.5 million doses a day, the US is still at least 6 months from herd immunity. Moreover, there is still a month or two lag period to get the next 100 million doses manufactured and distributed.

Therapeutic use for Brilacidin is now becoming urgent as deaths are 4 to 8 weeks behind infections. If B works, it will likely reduce time of infection, tissue damage and recovery time. We should all pray that Covid victims see immediate relief beginning with patient 1. Patient 1 is anticipated by end of next week if the trial begins this week as PRed.


Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation

FDA Grants IND Approval for Phase 2 Clinical Trial of Innovation Pharmaceuticals - Brilacidin for Treating
COVID-19

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News